Several studies in humans have reported that the elevation of serum galectin-3 levels was significantly associated with gastric cancer (9), renal failure (10, 11), diabetes mellitus (DM) (8), and heart failure (HF) (12, 13). This evidence concerns the gene LGALS3 and diabetes mellitus.